Article Text

Download PDFPDF
CASE REPORT
Palliative TACE for hepatic metastases of chromophobe renal cell carcinoma
  1. Peter D Whooley1,
  2. John Paul Flores2,
  3. Mehran Fotoohi3 and
  4. Bruce S Lin2
  1. 1 Department of Medicine, Virginia Mason Medical Center, Seattle, Washington, USA
  2. 2 Floyd & Delores Jones Cancer Institute, Virginia Mason Medical Center, Seattle, Washington, USA
  3. 3 Division of Interventional Radiology, Virginia Mason Medical Center, Seattle, Washington, USA
  1. Correspondence to Dr Bruce S Lin, Bruce.Lin{at}virginiamason.org

Abstract

We describe the case of a man with chromophobe renal cell carcinoma (chRCC) and numerous metastatic lesions restricted to the liver. Despite extensive courses of various systemic targeted chemotherapies, progressive disease was noted on CT and MRI and the patient suffered from persistent abdominal pain associated with his metastatic lesions. The liver lesions and associated symptoms were effectively palliated with serial transarterial chemoembolisation (TACE). While it is unclear if TACE has impacted his overall survival, this case encourages the use of TACE for palliative intent for patients with metastatic chRCC.

  • cancer intervention
  • oncology
  • urological cancer
  • pain (palliative care)
  • interventional radiology

Statistics from Altmetric.com

Footnotes

  • Contributors BSL and MF conceived of the presented manuscript. BSL, MF and JPF encouraged PDW to investigate the case and review the literature. PDW wrote the manuscript with support from JPF, MF and BSL. All authors provided literature review, as well as drafting the article and revising it critically for important intellectual content.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests BSL reports personal fees from Bayer HCC Advisory Board and personal fees from Exelixis HCC Advisory Board, outside the submitted work.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.